MedPath

A clinical trial to study the effect of doxycycline in patients of chronic obstructive pulmonary disease with stable symptoms

Phase 2
Completed
Conditions
Health Condition 1: null- Chronic obstructive pulmonary disease
Registration Number
CTRI/2011/091/000042
Lead Sponsor
Govt Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
72
Inclusion Criteria

1.Age > 40 years

2.Smoking history >10 packs years

3.Patients classified as GOLD criteria II and III

4.Ability to perform Pulmonary function tests

Exclusion Criteria

1.Patient with acute exacerbation (Anthonisen et al) / critically ill patients
2.Patient with moderate/severe exacerbation in last 4 weeks as defined by severity scale proposed by Cazzola et al.
3.Patient with active respiratory disease other than COPD (tuberculosis, lung malignancies, Bronchiectasis, pneumonia, bronchial asthma)
4.Patient with acute systemic/local infection
5.Patient with cardiac disease (CCF, Recent myocardial infarction, Cardiac arrhythmias)
6.Patient with gastrointestinal disorders (Gastro-esophageal reflux disorder, peptic ulcer, Undiagnosed abdominal pain)
7.Patient with renal or hepatic impairment
8.Patient with h/o hypersensitivity to tetracyclines
9.Patient receiving oral corticosteroids

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath